Active — Not RecruitingNot Applicable

Use of Artificial Intelligence by Urogynecologic Patients

United States125 participantsStarted 2024-07-22

Plain-language summary

The goal of this clinical trial is to learn about how Urogynecology patients use Artificial Intelligence (AI) Chatbots like ChatGPT, and how it affects healthcare decision making. The main question\[s\] it aims to answer are: * How does the AI Chatbot affect participants' understanding of diagnoses and participant satisfaction with a urogynecology consultation? * How accurate is the chatbot-provided diagnosis and counseling information? Participants will be asked to use the ChatGPT chatbot and ask it questions about the main problem the participant is seeing the doctor for, and will also be asked to fill out some questionnaires. Researchers will compare using the Chatbot before the visit, after the visit, or not at all to see if the way participants understand the information changes based on timing of use.

Who can participate

Age range

18 Years – 89 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * female * presenting for their initial evaluation by a urogynecology physician for one of the following: * urinary incontinence (UI) * lower urinary tract symptoms (LUTS) * pelvic organ prolapse (POP) * greater than or equal to18 and less than or equal to89 years old * any race/ethnicity * able to read or speak English or Spanish * able/willing to consent to participate Exclusion Criteria: * male * primary presenting problem other than UI, LUTS, or POP * non-English or non-Spanish speaking * pregnant or lactating, as this may affect patient treatment counseling * unable/unwilling to consent to participate

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Patient understanding of diagnosis and treatment - physician understanding of diagnosis

Timeframe: Baseline

Patient understanding of diagnosis and treatment - physician perception of participant understanding

Timeframe: Baseline

Patient understanding of diagnosis and treatment - participant understanding of diagnosis and treatment plan

Timeframe: Baseline and three month follow-up

Patient understanding of diagnosis and treatment - understanding of diagnosis

Timeframe: Baseline and three month follow-up

Patient understanding of diagnosis and treatment - decision making

Timeframe: Baseline and three month follow-up

Trial details

NCT IDNCT06481436

SponsorHartford Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-12-16

View on ClinicalTrials.gov More Uterovaginal Prolapse trials

Plain-language summary

Who can participate

Age range

18 Years – 89 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Patient understanding of diagnosis and treatment - physician understanding of diagnosis

Timeframe: Baseline

Patient understanding of diagnosis and treatment - physician perception of participant understanding

Timeframe: Baseline

Patient understanding of diagnosis and treatment - participant understanding of diagnosis and treatment plan